Medmira Stock Return On Equity
| MIR Stock | CAD 0.08 0.00 0.00% |
MedMira fundamentals help investors to digest information that contributes to MedMira's financial success or failures. It also enables traders to predict the movement of MedMira Stock. The fundamental analysis module provides a way to measure MedMira's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MedMira stock.
| Last Reported | Projected for Next Year | ||
| Return On Equity | 0.18 | 0.18 |
MedMira | Return On Equity |
MedMira Company Return On Equity Analysis
MedMira's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current MedMira Return On Equity | 0.18 |
Most of MedMira's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MedMira is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
MedMira Return On Equity Driver Correlations
Understanding the fundamental principles of building solid financial models for MedMira is extremely important. It helps to project a fair market value of MedMira Stock properly, considering its historical fundamentals such as Return On Equity. Since MedMira's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of MedMira's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of MedMira's interrelated accounts and indicators.
Click cells to compare fundamentals
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
MedMira Total Stockholder Equity
Total Stockholder Equity |
|
MedMira Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MedMira's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MedMira could also be used in its relative valuation, which is a method of valuing MedMira by comparing valuation metrics of similar companies.MedMira is currently under evaluation in return on equity category among its peers.
MedMira Current Valuation Drivers
We derive many important indicators used in calculating different scores of MedMira from analyzing MedMira's financial statements. These drivers represent accounts that assess MedMira's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of MedMira's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 276.5M | 79.0M | 88.5M | 62.8M | 56.5M | 33.0M | |
| Enterprise Value | 288.0M | 92.8M | 96.7M | 72.0M | 64.8M | 39.9M |
MedMira Fundamentals
| Return On Asset | -0.26 | ||||
| Operating Margin | (7.40) % | ||||
| Current Valuation | 60.09 M | ||||
| Shares Outstanding | 701.73 M | ||||
| Shares Owned By Insiders | 68.95 % | ||||
| Number Of Shares Shorted | 979 | ||||
| Price To Earning | (5.00) X | ||||
| Price To Sales | 146.45 X | ||||
| Revenue | 432.53 K | ||||
| Gross Profit | (512.51 K) | ||||
| EBITDA | (1.58 M) | ||||
| Net Income | (2.68 M) | ||||
| Cash And Equivalents | 1.06 K | ||||
| Total Debt | 9.27 M | ||||
| Current Ratio | 0.02 X | ||||
| Book Value Per Share | (0.02) X | ||||
| Cash Flow From Operations | (1.27 M) | ||||
| Short Ratio | 0.02 X | ||||
| Earnings Per Share | (0.01) X | ||||
| Beta | 10.73 | ||||
| Market Capitalization | 56.14 M | ||||
| Total Asset | 3.65 M | ||||
| Retained Earnings | (97.96 M) | ||||
| Working Capital | (14.03 M) | ||||
| Net Asset | 3.65 M |
About MedMira Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MedMira's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MedMira using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MedMira based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for MedMira Stock Analysis
When running MedMira's price analysis, check to measure MedMira's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedMira is operating at the current time. Most of MedMira's value examination focuses on studying past and present price action to predict the probability of MedMira's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedMira's price. Additionally, you may evaluate how the addition of MedMira to your portfolios can decrease your overall portfolio volatility.